Best response to a single dose of 90Y-ibritumomab following first-line treatment with chemotherapy alone (group A)
| Response . | In patients pretreated with chemotherapy alone, no. (%) . | ||
|---|---|---|---|
| Group A overall, n = 76 . | Stratum AI, n = 33* . | Stratum AII, n = 43 . | |
| CR | 21 (28) | 7 (21) | 14 (32.5) |
| CRu | 4 (5) | 1 (3) | 3 (7) |
| PR | 15 (20) | 9 (27) | 6 (14) |
| ORR | 40 (53) | 17 (52) | 23 (53) |
| Response . | In patients pretreated with chemotherapy alone, no. (%) . | ||
|---|---|---|---|
| Group A overall, n = 76 . | Stratum AI, n = 33* . | Stratum AII, n = 43 . | |
| CR | 21 (28) | 7 (21) | 14 (32.5) |
| CRu | 4 (5) | 1 (3) | 3 (7) |
| PR | 15 (20) | 9 (27) | 6 (14) |
| ORR | 40 (53) | 17 (52) | 23 (53) |
Includes 22 PRs after first-line chemotherapy treatment.